Development of prophylactic recombinant HPV58-attenuated Shigella live vector vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model.

Source:http://linkedlifedata.com/resource/pubmed/id/19204831

Download in:

View as

General Info

PMID
19204831